- Home
- SRPT
SRPT
Sarepta Therapeutics Inc. (DE)
as 01-17-2025 4:00pm EST
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | N/A | IPO Year: | 1997 |
| Target Price: | $179.38 | AVG Volume (30 days): | 726.5K |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $102.16 - $173.25 | Next Earning Date: | 02-26-2025 |
| Revenue: | $1,640,348,000 | Revenue Growth: | 48.45% |
| Revenue Growth (this year): | 50.24% | Revenue Growth (next year): | 71.04% |
Stock Insider Trading Activity of Sarepta Therapeutics Inc. (DE) (SRPT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wigzell Hans Lennart Rudolf | SRPT | Director | Dec 12 '24 | Sell | $124.84 | 10,500 | $1,310,820.00 | 22,840 | |
| Boor Kathryn Jean | SRPT | Director | Dec 5 '24 | Sell | $125.55 | 1,636 | $205,399.80 | 5,880 |
Latest Sarepta Therapeutics Inc. (DE) News
SRPT Breaking Stock News: Dive into SRPT Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
SRPT: Lowering target price to $95.00
Business Wire
5 days ago
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2024 Net Product Revenue
MT Newswires
11 days ago
RBC Cuts Price Target on Sarepta Therapeutics to $165 From $182, Keeps Outperform Rating
Business Wire
12 days ago
Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Zacks
12 days ago
SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell?
Business Wire
18 days ago
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Insider Monkey
20 days ago
Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now?
Simply Wall St.
23 days ago
Exploring High Growth Tech Stocks in the US December 2024
Compare SRPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRPT Sarepta Therapeutics Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.